{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-046655","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2022-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.575313+00:00","generated_at":"2026-06-20T23:58:58.668883+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Shareholders approve reverse stock split (1:50-1:100) and authorized share increase to 2.5B","bullets":["Reverse stock split approved with 306.5M votes for, 12.0M against (ratio range 1-for-50 to 1-for-100).","Authorized shares increased from 800M to 2.5B with 294.9M votes for, 23.4M against.","Consent solicitation commenced Nov 18, 2022, terminated Dec 20, 2022 upon approval.","No broker non-votes reported; both proposals passed with requisite affirmative votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-046655","json":"https://secwatch.observer/filing/0001140361-22-046655.json","markdown":"https://secwatch.observer/filing/0001140361-22-046655.md","text":"https://secwatch.observer/filing/0001140361-22-046655.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036122046655/0001140361-22-046655-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036122046655/ny20005429x3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T23:58:58.668883+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8e5b5a41088996ad08faf576ce183b4e19d67035","claim":"SANUWAVE Health, Inc. shareholders approved To approve an amendment to the Company's Articles of Incorporation to increase the number of authorized shares of Common Stock from 800,000,000 to 2,500,000,000 at the 2022-12-20 meeting.","evidence_excerpt":"Proposal 2. To approve an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of Common Stock from 800,000,000 to 2,500,000,000 . Votes For Votes Against Abstain Broker Non-Votes 294,922,676 23,364,904 1,128,525 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036122046655/0001140361-22-046655-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-20"}],"fact_type":"shareholder_vote"},{"claim_id":"debd67af27d193e4486e433cd36a0f6746bd10cf","claim":"SANUWAVE Health, Inc. shareholders approved To approve an amendment to the Company's Articles of Incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from 1-for-50 to 1-for-100 at the 2022-12-20 meeting.","evidence_excerpt":"Proposal 1. To approve an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the Company’s common stock, par value $0.001 (the “Common Stock”), at a reverse stock split ratio ranging from any whole number between 1-for-50 and 1-for-100, subject to and as determined by the Board of Directors. Votes For Votes Against Abstain Broker Non-Votes 306,476,740 11,981,209 958,156 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036122046655/0001140361-22-046655-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-20"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}